Images in cardiovascular ultrasound
A 64-year-old Japanese man was referred to our hospital because of palpitation. An electrocardiogram revealed firstdegree atrioventricular block without ST-T change. An echocardiography showed structural abnormality into the left ventricular outflow tract (LVOT), mitral valve leaflet cleft without mitral regurgitation, and single papillary muscle (loss of posterior papillary muscle) (Figs. 1, 2) . A structural abnormality was attached between the base of the intraventricular septum and anterior mitral leaflet, which was mobile in the cardiac cycle. Peak velocity of LVOT was 1.7 m/s. Cardiac systolic function was normal. We diagnosed accessory mitral valve tissue (AMVT) with mitral complex structural abnormality (mitral valve leaflet cleft and single papillary muscle).
AMVT is a rare congenital cardiac malformation. The age of AMVT diagnosis ranged from newborns to 77 years [1] . It was reported that the incidence of AMVT in adults was 1/26,000 echocardiogram [2] . Although the exact embryologic mechanism of AMVT formation is not clear, it may stem from the abnormal or incomplete separation of the mitral valve from the endocardial cushions [3] . AMVT is associated with other congenital intracardiac and vascular malformations such as ventricular septal defect [4] . In this case, we found AMVT with a combination of mitral valve leaflet cleft and single papillary muscle (loss of posterior papillary muscle). To our knowledge, this is the first reported case of AMVT with a combination of mitral valve leaflet cleft and single papillary muscle.
An echocardiography can be considered the gold standard modality for the diagnosis of AMVT with other cardiac abnormality.
Although single papillary muscle usually combined the parachute mitral valve, the parachute mitral valve was not observed in this case. The majority of patients with AMVT have no symptoms, such as chest pain, palpitation, and syncope [5] [6] [7] . However, this patient was referred to our hospital because of palpitation. No arrhythmia was observed in electrocardiogram monitoring. Conflict of interest Koichiro Imai, Mariko Kawata, Hiroyuki Okura, and Shiro Uemura declare that they have no conflicts of interest.
Human rights statements and informed consent All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later revisions. Informed consent was obtained from all patients included in the study.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http:// creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
